TD Cowen analyst Yaron Werber reiterated a Buy rating and $59.00 price target on Ionis Pharmaceuticals (NASDAQ: IONS).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE